1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Arix Bioscience

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Private Equity Firm

Location

London UK

Alternative Asset Classes

PE

Established

2016

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

13
Arix Bioscience is a private equity firm that focuses investments in innovative health and life sciences companies, particularly those developing from university research. The firm makes investments both from its own balance sheet and through an evergreen fund.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Growth, PIPE, Venture (General)
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

4 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Investor Relations Officer London, UK PE VC
Analyst London, UK PE VC
Chairman London, UK PE VC
Interim Chief Executive Officer London, UK PE VC

Showing 4 of 4 known decision makers at Arix Bioscience

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.